Currently, the conventional treatment for Parkinson's disease (PD) mainly is based on levodopa supplement （Gold Standard） and others. However, partial patients stayed non-sensitive to the classical drug use. Besides, long-term and intermittent use of levodopa is clinically associated with motor complications, such as freezing foot or freezing of gait, which has been a more troublesome question in PD treatment process. Recently alternative treatments: deep brain stimulation (DBS), neuroprotective agents, and Medicinal herbs have gradually been widely used in practice. Alzheimer's disease (AD) is characterized by loss of neurons and synapse in cortex and subcortex. The amyloid, plagues and neurofirillary tangles are clearly observed in the AD brain. Some completing treatment hypotheses have existed for decades: Cholinergic hypothesis, amyloid hypothesis and Tau hypothesis, as well as the idea of traditional Chinese medicine, e.g., Ginkgo, S. officinalis and S. lavandulaefolia, for promoting memory and improving the cognitive functions. Wilson's disease (WD), or hepatolenticular degeneration, is an autosomal recessive inheritance disorder of copper metabolism caused by ATP7B gene mutation. Approximately 80% of WD patients are better controlled in the authors' experience of anticopper and the liver/brain protective managements, so recommended that the treatment for WD is integrated traditional Chinese with modern medicines. Moreover, attention should be also paid to other kind of rare refractory disorder: motor neuronal disease or amyotrophic lateral sclerosis (ALS). It is worthy to emphasize that the majority of authors would hope to introduce the scientific contribution of alternative treatments: from the cell-protective effects to the chemical target treatments out of the traditional Chinese medicinal herbs.
Keywords: Neurodegenerative diseases; Parkinson's disease; Alzheimer's disease; Wilson's disease; amyotrophic lateral sclerosis; freezing of gait; drug development; alternative medicine; traditional Chinese medicine.
Xiao-Ping Wang (Guest Editor)
Section of Neurodegenerative Diseases School of Medicine Shanghai Jiao-Tong University Shanghai City PR China E-mail: x_p_wang@sjtu.edu.cn
